DaVita HealthCare Partners Inc (DVA)

Receivables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 12,140,150 11,911,290 11,738,650 11,665,040 11,609,900 11,636,980 11,626,610 11,616,360 11,618,800 11,580,150 11,565,900 11,529,370 11,550,610 11,543,870 11,523,880 11,486,600 11,388,470 11,311,010 11,254,260 11,298,510
Receivables US$ in thousands 2,415,910 2,377,790 2,366,950 2,382,210 2,550,650 2,493,270 2,634,820 2,501,740 2,410,510 2,491,080 2,550,680 2,604,490 2,438,820 2,428,210 2,428,830 2,370,540 2,305,060 2,391,610 2,551,590 2,485,650
Receivables turnover 5.03 5.01 4.96 4.90 4.55 4.67 4.41 4.64 4.82 4.65 4.53 4.43 4.74 4.75 4.74 4.85 4.94 4.73 4.41 4.55

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $12,140,150K ÷ $2,415,910K
= 5.03

DaVita Inc's receivables turnover ratio has been relatively stable over the past eight quarters, ranging from 4.41 to 5.03. The ratio indicates how efficiently the company collects outstanding receivables from its customers during a specific period.

The increasing trend from Q1 2022 to Q4 2023 suggests that DaVita has been improving its ability to convert accounts receivable into cash. A higher turnover ratio is generally favorable and indicates that the company is efficiently managing its receivables.

However, it is important to consider industry norms and compare DaVita's ratio with its competitors to assess its effectiveness in collecting receivables. Additionally, any significant fluctuations in the ratio should be further investigated to understand the underlying reasons for the change.


Peer comparison

Dec 31, 2023

Company name
Symbol
Receivables turnover
DaVita HealthCare Partners Inc
DVA
5.03
Progyny Inc
PGNY
3.80
Sotera Health Co
SHC
6.65